You are here: Industry Insights > COVID-19

News List

Pfizer Begins Testing COVID-19 Vaccine Targeted to Omicron drugs.com
January 25, 2022
Pfizer Inc. announced Tuesday that it has launched a trial that will compare its existing COVID-19 vaccine against...
Chung-Ang University researchers show gold-paved path towards faster COVID-19 diagnosis ExpressPharma
January 24, 2022
Researchers use gold nanoparticles to develop a new molecular diagnostic platform that considerably reduces the time required for COVID-19 detection.
Moderna vax may lead to fewer breakthrough COVID infections than Pfizer ExpressPharma
January 24, 2022
A research, published in the Journal of the American Medical Association, found those who received the Moderna vaccine were less likely to be hospitalised, compared to recipients of the Pfizer-BioNTech vaccine.
Chinese mainland reports fewer daily local COVID-19 cases NMPA/Xinhua
January 24, 2022
The Chinese mainland recorded 23 locally transmitted COVID-19 infections for Thursday, lower than 43 a day earlier, according to the latest data from the National Health Commission.
Fiber Optic Components Market worth $37.5 billion by 2027 - Exclusive Report by MarketsandMarkets™ prnewswire
January 24, 2022
According to the new research report the "Fiber Optic Components Market with Covid-19 impact by Component (Transceivers, AOCs, Cables, Amplifiers, Splitters, Connectors, Circulators), Data Rate...
Banty Presents Successful COVID-19 Educational Event 'Let Kids Be Kids' prnasia
January 24, 2022
On Wednesday, January 19, video conferencing solution and virtual live event producer, Banty Inc., presented Let Kids Be Kids, an online educational gathering focused on COVID-19's impact on children.
Feds may limit authorizating monoclonal antibody treatments FirstWordPharma
January 24, 2022
According to a source familiar with the decision-making, US regulators are considering limiting the authorization of certain monoclonal antibody treatments for COVID-19 that have not proved effective against the Omicron variant, reported CNN.
MU study identifies mutations specific to Omicron variant FirstWordPharma
January 24, 2022
While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the Omicron variant's high rate of infection.
Fourth COVID vaccine shot sharply raises serious illness resistance for over 60s: Israel FirstWordPharma
January 24, 2022
Israel's health ministry says a fourth dose of COVID-19 vaccine given to people over 60 in the country made them three times more resistant to serious illness than thrice-vaccinated people in the same age group, as reported in U.S. News & World Report.
Audits in the time of COVID-19 – Implications for a CMO CPhIonline
January 24, 2022
Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page